BRIEF-Dis-Chem Pharmacies HY HEPS 36.0 Cents

  • Reuters
  • Stock Market News
BRIEF-Dis-Chem Pharmacies HY HEPS 36.0 Cents
Credit: © Reuters.

Nov 5 (Reuters) - Dis-Chem Pharmacies Ltd DCPJ.J :

* DIS-CHEM PHARMACIES LTD - HY HEPS 36.0 CENTS

* DIS-CHEM PHARMACIES LTD - DURING SIX-MONTH PERIOD FROM 1 MARCH 2020 TO 31 AUGUST 2020, DIS-CHEM RECORDED GROUP REVENUE GROWTH OF 8.1% TO R12.8 BILLION.

* DIS-CHEM PHARMACIES LTD - FOR 9 WEEKS TO 31 OCTOBER 2020, GROUP REVENUE HAS GROWN BY 7.1% FROM PRIOR COMPARABLE PERIOD.

* DIS-CHEM PHARMACIES LTD - COSTS DIRECTLY RELATED TO COVID-19 AMOUNTED TO R45.4 MILLION IN HY

* DIS-CHEM PHARMACIES LTD - HY REVENUE R12.8 BILLION VERSUS R11.8 BILLION AS REPORTED A YEAR EARLIER

* DIS-CHEM PHARMACIES LTD - DECIDED TO PRESERVE CASH RESOURCES IN ORDER TO FUND THESE ACQUISITIONS AND NOT DECLARE A DIVIDEND.

* DIS-CHEM PHARMACIES LTD - EXPECTS THAT CONSUMER WILL CONTINUE TO REMAIN CONSTRAINED AND FULL EXTENT OF IMPACT OF COVID-19 STILL UNKNOWN

* DIS-CHEM PHARMACIES LTD - NOT DECLARE A DIVIDEND

* DIS-CHEM PHARMACIES LTD - EXPECTS THAT CONSUMER WILL CONTINUE TO REMAIN CONSTRAINED

* DIS-CHEM PHARMACIES LTD - INVESTIGATING AN ACQUISITION OF A COMMUNITY BASED PHARMACY GROUP

* DIS-CHEM PHARMACIES LTD - GROSS MARGIN PRESSURE CURRENTLY BEING EXPERIENCED BY GROUP IS EXPECTED TO CONTINUE INTO SECOND HALF OF YEAR

* DIS-CHEM PHARMACIES LTD - ADVANCED STAGES OF CONCLUDING ACQUISITION OF A STRATEGIC INTEREST IN A HEALTHCARE ASSET

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100